Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-014722
Filing Date
2025-04-21
Accepted
2025-04-21 16:07:00
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-21

Document Format Files

Seq Description Document Type Size
1 ARS ny20044209x3_ars.pdf ARS 3954063
  Complete submission text file 0001140361-25-014722.txt   5446695
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40502 | Film No.: 25853189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)